
Kevin E. Weddington
Examiner (ID: 6966)
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1614, 1205, 1629, 2899 |
| Total Applications | 3386 |
| Issued Applications | 2180 |
| Pending Applications | 434 |
| Abandoned Applications | 815 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4786182
[patent_doc_number] => 20080139511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'Combination Therapies Employing Ace Inhibitors and Uses Thereof for the Treatment of Diabetic Disorders'
[patent_app_type] => utility
[patent_app_number] => 12/033392
[patent_app_country] => US
[patent_app_date] => 2008-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9652
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20080139511.pdf
[firstpage_image] =>[orig_patent_app_number] => 12033392
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/033392 | Combination Therapies Employing Ace Inhibitors and Uses Thereof for the Treatment of Diabetic Disorders | Feb 18, 2008 | Abandoned |
Array
(
[id] => 11479377
[patent_doc_number] => 09585898
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-07
[patent_title] => 'Method for the reduction of dangerous blood sugar levels'
[patent_app_type] => utility
[patent_app_number] => 12/069505
[patent_app_country] => US
[patent_app_date] => 2008-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3071
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12069505
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/069505 | Method for the reduction of dangerous blood sugar levels | Feb 10, 2008 | Issued |
Array
(
[id] => 4753323
[patent_doc_number] => 20080161399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'AGENT FOR REDUCTION OF OXIDIZED ALBUMIN LEVEL'
[patent_app_type] => utility
[patent_app_number] => 12/025539
[patent_app_country] => US
[patent_app_date] => 2008-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4551
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20080161399.pdf
[firstpage_image] =>[orig_patent_app_number] => 12025539
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/025539 | AGENT FOR REDUCTION OF OXIDIZED ALBUMIN LEVEL | Feb 3, 2008 | Abandoned |
Array
(
[id] => 8214290
[patent_doc_number] => 08193168
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-05
[patent_title] => 'Use of a TRPM5 inhibitor to regulate insulin and GLP-1 release'
[patent_app_type] => utility
[patent_app_number] => 12/025488
[patent_app_country] => US
[patent_app_date] => 2008-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 23872
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/193/08193168.pdf
[firstpage_image] =>[orig_patent_app_number] => 12025488
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/025488 | Use of a TRPM5 inhibitor to regulate insulin and GLP-1 release | Feb 3, 2008 | Issued |
Array
(
[id] => 4456396
[patent_doc_number] => 07893097
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-22
[patent_title] => 'Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water'
[patent_app_type] => utility
[patent_app_number] => 12/012413
[patent_app_country] => US
[patent_app_date] => 2008-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3524
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/893/07893097.pdf
[firstpage_image] =>[orig_patent_app_number] => 12012413
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/012413 | Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water | Feb 1, 2008 | Issued |
Array
(
[id] => 4698921
[patent_doc_number] => 20080221105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'SOLUBLE EPOXIDE HYDROLASE INHIBITORS FOR TREATMENT OF METABOLIC SYNDROME AND RELATED DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/021247
[patent_app_country] => US
[patent_app_date] => 2008-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 18116
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20080221105.pdf
[firstpage_image] =>[orig_patent_app_number] => 12021247
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/021247 | SOLUBLE EPOXIDE HYDROLASE INHIBITORS FOR TREATMENT OF METABOLIC SYNDROME AND RELATED DISORDERS | Jan 27, 2008 | Abandoned |
Array
(
[id] => 9389453
[patent_doc_number] => 08686051
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-01
[patent_title] => 'Pharmaceutical composition for treatment of diabetic complications'
[patent_app_type] => utility
[patent_app_number] => 12/524823
[patent_app_country] => US
[patent_app_date] => 2008-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9604
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12524823
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/524823 | Pharmaceutical composition for treatment of diabetic complications | Jan 23, 2008 | Issued |
Array
(
[id] => 4846490
[patent_doc_number] => 20080182898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'Treatment of metabolic syndrome with norfluoxetine'
[patent_app_type] => utility
[patent_app_number] => 12/011034
[patent_app_country] => US
[patent_app_date] => 2008-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9461
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20080182898.pdf
[firstpage_image] =>[orig_patent_app_number] => 12011034
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/011034 | Treatment of metabolic syndrome with norfluoxetine | Jan 22, 2008 | Abandoned |
Array
(
[id] => 9552343
[patent_doc_number] => 08759391
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-24
[patent_title] => 'Topical anesthetic for rapid local anesthesia'
[patent_app_type] => utility
[patent_app_number] => 12/015113
[patent_app_country] => US
[patent_app_date] => 2008-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2307
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12015113
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/015113 | Topical anesthetic for rapid local anesthesia | Jan 15, 2008 | Issued |
Array
(
[id] => 4676900
[patent_doc_number] => 20080214531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Methods and compositions for the treatment of insulin resistance, diabetes, and diabetes-associated dyslipdemia'
[patent_app_type] => utility
[patent_app_number] => 12/005887
[patent_app_country] => US
[patent_app_date] => 2007-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10760
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214531.pdf
[firstpage_image] =>[orig_patent_app_number] => 12005887
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/005887 | Methods for the treatment of diabetes-associated dyslipdemia | Dec 27, 2007 | Issued |
Array
(
[id] => 4887756
[patent_doc_number] => 20080262088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'METHODS, COMPOUNDS, AND COMPOSITIONS FOR TREATING METABOLIC DISORDERS AND DIABETES'
[patent_app_type] => utility
[patent_app_number] => 11/963038
[patent_app_country] => US
[patent_app_date] => 2007-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21230
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20080262088.pdf
[firstpage_image] =>[orig_patent_app_number] => 11963038
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/963038 | METHODS, COMPOUNDS, AND COMPOSITIONS FOR TREATING METABOLIC DISORDERS AND DIABETES | Dec 20, 2007 | Abandoned |
Array
(
[id] => 4846415
[patent_doc_number] => 20080182823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'POLYMER-LINKED-BIOPHOSPHONATE INHALANT FORMULATIONS AND METHODS FOR USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 11/963666
[patent_app_country] => US
[patent_app_date] => 2007-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8282
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20080182823.pdf
[firstpage_image] =>[orig_patent_app_number] => 11963666
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/963666 | POLYMER-LINKED-BIOPHOSPHONATE INHALANT FORMULATIONS AND METHODS FOR USING THE SAME | Dec 20, 2007 | Abandoned |
Array
(
[id] => 4964877
[patent_doc_number] => 20080107697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'Cosmetic composition comprising at least one polymer particle dispersed in at least one liquid fatty phase and at least one ester of at least one acid and at least one polyol ester'
[patent_app_type] => utility
[patent_app_number] => 12/004050
[patent_app_country] => US
[patent_app_date] => 2007-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13942
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20080107697.pdf
[firstpage_image] =>[orig_patent_app_number] => 12004050
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/004050 | Cosmetic composition comprising at least one polymer particle dispersed in at least one liquid fatty phase and at least one ester of at least one acid and at least one polyol ester | Dec 19, 2007 | Issued |
Array
(
[id] => 4846495
[patent_doc_number] => 20080182903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'Formulation of a composition for treating various conditions by using lotion/cream including L-Arginine'
[patent_app_type] => utility
[patent_app_number] => 11/953092
[patent_app_country] => US
[patent_app_date] => 2007-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1788
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20080182903.pdf
[firstpage_image] =>[orig_patent_app_number] => 11953092
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/953092 | Formulation of a composition for treating various conditions by using lotion/cream including L-Arginine | Dec 9, 2007 | Abandoned |
Array
(
[id] => 4939485
[patent_doc_number] => 20080076804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'METHODS FOR INHIBITING AND BREAKING AGE COMPLEX FORMATION'
[patent_app_type] => utility
[patent_app_number] => 11/952024
[patent_app_country] => US
[patent_app_date] => 2007-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6824
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20080076804.pdf
[firstpage_image] =>[orig_patent_app_number] => 11952024
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/952024 | Methods for inhibiting and breaking AGE complex formation | Dec 5, 2007 | Issued |
Array
(
[id] => 6375249
[patent_doc_number] => 20100075997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'USE OF PKC INHIBITORS IN TRANSPLANTATION'
[patent_app_type] => utility
[patent_app_number] => 12/517207
[patent_app_country] => US
[patent_app_date] => 2007-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4736
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20100075997.pdf
[firstpage_image] =>[orig_patent_app_number] => 12517207
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/517207 | USE OF PKC INHIBITORS IN TRANSPLANTATION | Dec 4, 2007 | Abandoned |
Array
(
[id] => 5310771
[patent_doc_number] => 20090018052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-15
[patent_title] => 'Treatment of Diabetes and Related Pathologies'
[patent_app_type] => utility
[patent_app_number] => 11/931672
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6731
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20090018052.pdf
[firstpage_image] =>[orig_patent_app_number] => 11931672
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/931672 | Treatment of Diabetes and Related Pathologies | Oct 30, 2007 | Abandoned |
Array
(
[id] => 4682803
[patent_doc_number] => 20080249029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Methods for Treating Skin Pigmentation'
[patent_app_type] => utility
[patent_app_number] => 11/929488
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 12956
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20080249029.pdf
[firstpage_image] =>[orig_patent_app_number] => 11929488
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/929488 | Methods for Treating Skin Pigmentation | Oct 29, 2007 | Abandoned |
Array
(
[id] => 5331416
[patent_doc_number] => 20090111893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-30
[patent_title] => 'METHOD OF LOWERING BLOOD GLUCOSE AND METHOD OF PREVENTING OR TREATING BLOOD GLUCOSE AND METHOD OF PREVENTING OR TREATING DIABETES AND OBESITY'
[patent_app_type] => utility
[patent_app_number] => 11/923064
[patent_app_country] => US
[patent_app_date] => 2007-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3134
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20090111893.pdf
[firstpage_image] =>[orig_patent_app_number] => 11923064
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/923064 | Method of lowering blood glucose and method of treating diabetes and obesity | Oct 23, 2007 | Issued |
Array
(
[id] => 5272088
[patent_doc_number] => 20090075864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'COMBINATION THERAPY COMPRISING GLUCOSE REABSORPTION INHIBITORS AND RETINOID-X RECEPTOR MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 11/923187
[patent_app_country] => US
[patent_app_date] => 2007-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15173
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20090075864.pdf
[firstpage_image] =>[orig_patent_app_number] => 11923187
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/923187 | Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators | Oct 23, 2007 | Issued |